CN114276408A - Extraction method and application of acanthopanax senticosus glycoprotein - Google Patents
Extraction method and application of acanthopanax senticosus glycoprotein Download PDFInfo
- Publication number
- CN114276408A CN114276408A CN202210056639.6A CN202210056639A CN114276408A CN 114276408 A CN114276408 A CN 114276408A CN 202210056639 A CN202210056639 A CN 202210056639A CN 114276408 A CN114276408 A CN 114276408A
- Authority
- CN
- China
- Prior art keywords
- glycoprotein
- acanthopanax senticosus
- leaching
- acanthopanax
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001632410 Eleutherococcus senticosus Species 0.000 title claims abstract description 124
- 102000003886 Glycoproteins Human genes 0.000 title claims abstract description 109
- 108090000288 Glycoproteins Proteins 0.000 title claims abstract description 109
- 238000000605 extraction Methods 0.000 title claims abstract description 38
- 238000002386 leaching Methods 0.000 claims abstract description 35
- 239000000243 solution Substances 0.000 claims abstract description 28
- 238000010438 heat treatment Methods 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 23
- 239000007853 buffer solution Substances 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 37
- 102000004169 proteins and genes Human genes 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 26
- 238000000502 dialysis Methods 0.000 claims description 23
- 239000000287 crude extract Substances 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 7
- 230000003712 anti-aging effect Effects 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 31
- 239000008055 phosphate buffer solution Substances 0.000 abstract 3
- 210000001519 tissue Anatomy 0.000 description 14
- 238000002835 absorbance Methods 0.000 description 11
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 10
- 229940118019 malondialdehyde Drugs 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 102000019197 Superoxide Dismutase Human genes 0.000 description 8
- 108010012715 Superoxide dismutase Proteins 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000002203 pretreatment Methods 0.000 description 5
- 239000012465 retentate Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229960001031 glucose Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- -1 GSH-Px Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
技术领域technical field
本发明涉及生物化学技术领域,尤其涉及一种刺五加糖蛋白的提取方法和应用。The invention relates to the technical field of biochemistry, in particular to an extraction method and application of Acanthopanax senticosus glycoprotein.
背景技术Background technique
糖蛋白是寡糖链与多肽以多种形式共价相连且具有生物活性的物质,糖蛋白为生物体内重要生物大分子之一,广泛存在于动植物和微生物中,甚至在单细胞有机体和病毒中也有发现,其以各种形式、种类分布于生物体的细胞内外液及组织中,构成生物体内的多种活性物质。天然糖蛋白具有抗氧化、抗肿瘤、提高免疫力等生理活性。糖蛋白对于生长发育、信息传递、免疫系统、神经系统等多种生命活动起重要作用,同时与多种疾病(如心血管疾病、肝肾病、糖尿病及肿瘤癌症等)的发生相关。Glycoproteins are substances in which oligosaccharide chains and polypeptides are covalently linked in various forms and have biological activity. Glycoproteins are one of the important biological macromolecules in living organisms and widely exist in animals, plants and microorganisms, even in single-celled organisms and viruses. It is also found in various forms and types that are distributed in the intracellular and extracellular fluids and tissues of the organism, and constitute a variety of active substances in the organism. Natural glycoproteins have physiological activities such as antioxidant, anti-tumor, and immunity enhancement. Glycoproteins play an important role in various life activities such as growth and development, information transmission, immune system, nervous system, etc., and are also related to the occurrence of various diseases (such as cardiovascular disease, liver and kidney disease, diabetes, tumor and cancer, etc.).
刺五加,又称刺拐棒、五加参、刺五甲、五加皮等,为五加科五加属植物,分布于中国黑龙江、吉林、辽宁、河北和山西,刺五加是一种营养丰富、具有多种生理功能和开发潜力的根茎类药材。刺五加用途广泛,具有益气健脾、补肾安神等功效,多用于治疗脾肺气虚,体虚乏力,食欲不振,肺肾两虚,久咳虚喘,肾虚腰膝酸痛,心脾不足,失眠多梦等症状。Acanthopanax senticosus, also known as Acanthopanax quinquefolius, Acanthopanax quinquefolius, Acanthopanax senticosus, Acanthopanax senticosus, etc., is a plant of the genus Araliaceae, distributed in Heilongjiang, Jilin, Liaoning, Hebei and Shanxi, China. It is a rhizome medicinal material with rich nutrition, various physiological functions and development potential. Acanthopanax senticosus has a wide range of uses, with the effects of invigorating the spleen, invigorating the spleen, nourishing the kidney and soothing the nerves. Insomnia and other symptoms.
但至今尚未见有关刺五加糖蛋白的提取方法,现有技术中提及的刺五加提取物为粗提物,成分复杂,缺乏深入研究意义,其中糖蛋白的含量较低且纯度不够,无法进一步高端应用。But so far, no method for extracting glycoproteins from Acanthopanax senticosus has been found. The extracts of Acanthopanax senticosus mentioned in the prior art are crude extracts with complex components and lack of in-depth research significance. Further high-end applications.
发明内容SUMMARY OF THE INVENTION
针对现有技术存在的问题,本发明提供一种刺五加糖蛋白的提取方法和应用。Aiming at the problems existing in the prior art, the present invention provides an extraction method and application of Acanthopanax senticosus glycoprotein.
第一方面,本发明提供一种刺五加糖蛋白的提取方法,包括将刺五加粗粉进行加热浸提的步骤,其中,浸提溶液为pH为5-9的PBS缓冲溶液,浸提温度为30-40℃,所述加热浸提的过程中还采用摇床辅助。In the first aspect, the present invention provides a method for extracting glycoprotein from Acanthopanax senticosus, including the step of heating and leaching the coarse powder of Acanthopanax senticosus, wherein the leaching solution is a PBS buffer solution with a pH of 5-9, and the leaching temperature is The temperature is 30-40°C, and a shaker is also used to assist in the process of the heating and leaching.
现有技术一般采用水提醇沉的方法从刺五加药材中提取活性成分,然后经过一系列提纯步骤得到纯度尚可的刺五加提取物,即现有的方法既繁杂,且所得产品品质一般。本发明研究发现,采用pH为5-9的PBS缓冲溶液作为浸提溶液,在特定浸提温度下并辅以摇床配合提取,可以提高糖蛋白提取率,所得刺五加糖蛋白结构稳定,同时也确保了糖蛋白的活性,且本发明的提取方法操作简单、条件温和,具有良好的重复再现性,易于推广应用。In the prior art, the method of water extraction and alcohol precipitation is generally used to extract active ingredients from the medicinal materials of Acanthopanax senticosus, and then a series of purification steps are performed to obtain the extract of Acanthopanax senticosus with acceptable purity, that is, the existing method is complicated and the quality of the obtained product is generally. According to the research of the present invention, the use of PBS buffer solution with pH of 5-9 as the leaching solution, at a specific leaching temperature and supplemented by a shaking table, can improve the extraction rate of glycoprotein, the obtained Acanthopanax senticosus glycoprotein has a stable structure, and at the same time The activity of the glycoprotein is also ensured, and the extraction method of the present invention has simple operation, mild conditions, good repeatability, and is easy to popularize and apply.
进一步地,所述加热浸提过程中,摇床的振摇速率为40-300r/min。Further, during the heating and leaching process, the shaking rate of the shaker is 40-300 r/min.
进一步地,所述加热浸提过程中,料液比为1:10-1:20g/mL,浸提时间为6-48h,浸提次数为2-4次。Further, in the heating leaching process, the ratio of material to liquid is 1:10-1:20g/mL, the leaching time is 6-48h, and the number of times of leaching is 2-4 times.
在本发明一个优选实施方式中,所述加热浸提过程中,浸提溶液为pH为8的PBS缓冲溶液,浸提温度为30℃,摇床的振摇速率为160r/min,料液比为1:15g/mL,浸提时间为12h,浸提次数为3次。In a preferred embodiment of the present invention, during the heating leaching process, the leaching solution is a PBS buffer solution with a pH of 8, the leaching temperature is 30° C., the shaking rate of the shaker is 160 r/min, and the ratio of material to liquid is 160 r/min. It is 1:15g/mL, the extraction time is 12h, and the extraction times are 3 times.
进一步地,在进行所述加热浸提得到刺五加糖蛋白粗提液后,还包括去除游离蛋白和透析冻干的步骤。Further, after the heating extraction is performed to obtain the crude extract of Acanthopanax senticosus glycoprotein, the steps of removing free protein and dialysis and freeze-drying are also included.
在本发明提供的具体实施方式中,所述提取方法包括以下步骤:In the specific embodiment provided by the present invention, the extraction method comprises the following steps:
(1)预处理:将刺五加药材粉碎成刺五加粗粉;(1) Pre-treatment: pulverize the medicinal materials of Acanthopanax senticosus into coarse powder of Acanthopanax senticosus;
(2)摇床辅助+加热浸提:将步骤(1)得到的刺五加粉末与pH=5-9PBS缓冲溶液按1:10-1:20g/mL的料液比混合均匀,摇床振摇速率为40-300r/min,30-40℃下加热浸提6-48h,提取次数为1-4次,然后过滤,合并滤液,得到刺五加糖蛋白粗提液;(2) Shaker-assisted + heating extraction: Mix the Acanthopanax senticosus powder obtained in step (1) with pH=5-9 PBS buffer solution at a material-to-liquid ratio of 1:10-1:20 g/mL, and shake the The shaking rate is 40-300r/min, heating and leaching at 30-40°C for 6-48h, and the extraction times are 1-4 times, then filter, and combine the filtrates to obtain the crude extract of Acanthopanax senticosus glycoprotein;
(3)除游离蛋白:将步骤(2)得到的刺五加糖蛋白粗提液采用Sevage法去除游离蛋白,得到刺五加糖蛋白溶液;(3) removal of free protein: the crude extract of Acanthopanax senticosus glycoprotein obtained in step (2) adopts the Sevage method to remove free protein to obtain a solution of Acanthopanax senticosus glycoprotein;
(4)透析冻干:将步骤(3)得到的刺五加糖蛋白溶液装入透析袋,置于蒸馏水中,透析48h,将透析截留物冷冻干燥,即得刺五加糖蛋白粉末。(4) dialysis freeze-drying: put the Acanthopanax senticosus glycoprotein solution obtained in step (3) into a dialysis bag, place in distilled water, dialyze for 48 hours, and freeze-dry the dialysis retentate to obtain the Acanthopanax senticosus glycoprotein powder.
本发明通过摇床辅助,使用PBS溶液进行提取,得到蛋白含量约为15%的糖蛋白粗提物,然后对游离蛋白进去除,获得剩余的与糖连接的蛋白即为糖蛋白,后再进一步纯化,得到纯度较高的刺五加糖蛋白组分。本发明的刺五加糖蛋白的提取方法具有设计合理、工艺简单、操作方便,产品提取率高、纯度高、性质稳定,无需大量使用有机试剂,制备成本低,易于推广应用等优点。In the present invention, the PBS solution is used for extraction with the aid of a shaker to obtain a crude glycoprotein extract with a protein content of about 15%, and then the free protein is removed to obtain the remaining protein linked with sugar, which is glycoprotein, and then further Purification to obtain the glycoprotein fraction of Acanthopanax senticosus with higher purity. The method for extracting glycoprotein from Acanthopanax senticosus has the advantages of reasonable design, simple process, convenient operation, high product extraction rate, high purity, stable properties, no need to use a large amount of organic reagents, low preparation cost, easy popularization and application, and the like.
需要说明的是,本发明所述粗粉即是指全部通过一号筛,但混有能通过三号筛不超过20%的粉末。It should be noted that the coarse powder mentioned in the present invention means that all the powders pass through the No. 1 sieve, but mixed with the powder that can pass through the No. 3 sieve no more than 20%.
进一步地,采用Sevage法去除游离蛋白具体包括:在所述刺五加糖蛋白粗提液中加入Sevage试剂,在4℃条件下,振摇1h,然后以9000r/min的转速离心15-20min,收集上清液,重复该步骤至没有蛋白层析出。Further, using the Sevage method to remove free protein specifically includes: adding Sevage reagent to the crude extract of Acanthopanax senticosus glycoprotein, shaking at 4°C for 1 hour, then centrifuging at 9000r/min for 15-20min, collecting For the supernatant, repeat this step until no protein layer is precipitated.
进一步优选地,所述Sevage试剂的用量为所述刺五加糖蛋白粗提液的1/4体积量,所述Sevage试剂由正丁醇与氯仿按1:4的比例混合而成。Further preferably, the dosage of the Sevage reagent is 1/4 of the volume of the crude extract of Acanthopanax senticosus, and the Sevage reagent is prepared by mixing n-butanol and chloroform in a ratio of 1:4.
进一步地,透析操作在4℃下进行,所用透析袋的截留分子量为0.1kDa,透析过程中每6-7小时更换一次透析液。Further, the dialysis operation was performed at 4° C., the molecular weight cut-off of the dialysis bag used was 0.1 kDa, and the dialysate was replaced every 6-7 hours during the dialysis process.
第二方面,本发明提供一种刺五加糖蛋白,由上述刺五加糖蛋白的提取方法提取得到。In a second aspect, the present invention provides a glycoprotein from Acanthopanax senticosus, which is extracted by the above-mentioned method for extracting glycoprotein from Acanthopanax senticosus.
进一步地,所述刺五加糖蛋白中糖含量与蛋白质含量之和为50-80%,即刺五加糖蛋白的纯度为50-80%。Further, the sum of sugar content and protein content in the Acanthopanax senticosus glycoprotein is 50-80%, that is, the purity of the Acanthopanax senticosus glycoprotein is 50-80%.
第三方面,本发明提供上述刺五加糖蛋白在制备具有抗皮肤氧化和/或抗衰老的功能性产品中的应用。In a third aspect, the present invention provides the application of the above-mentioned Acanthopanax senticosus glycoprotein in the preparation of a functional product with anti-skin oxidation and/or anti-aging.
本发明通过在体与离体实验证明了刺五加糖蛋白在抗氧化与皮肤光损伤方面具有显著作用,为刺五加糖蛋白应用于护肤品的研发提供了参考依据。The present invention proves that the acanthopanax senticosus glycoprotein has a significant effect on anti-oxidation and skin photodamage through in vivo and in vitro experiments, and provides a reference for the research and development of the acanthopanax senticosus glycoprotein applied to skin care products.
本发明提供了一种刺五加糖蛋白的提取方法和应用,通过采用pH为5-9的PBS缓冲溶液作为浸提溶液,在特定浸提温度下并辅以摇床配合提取,可以提高糖蛋白提取率,所得刺五加糖蛋白结构稳定,同时也确保了糖蛋白的活性,且本发明的提取方法操作简单、条件温和,具有良好的重复再现性,易于推广应用。The invention provides a method and application for extracting glycoprotein from Acanthopanax senticosus. By using a PBS buffer solution with a pH of 5-9 as a leaching solution, and extracting at a specific leaching temperature and supplemented by a shaking table, the glycoprotein can be improved. The extraction rate is high, the obtained Acanthopanax senticosus glycoprotein is stable in structure, and the activity of the glycoprotein is also ensured, and the extraction method of the invention has simple operation, mild conditions, good repeatability, and is easy to popularize and apply.
附图说明Description of drawings
图1为本发明实施例1的刺五加糖蛋白对小鼠皮肤组织中SOD活力的影响;Fig. 1 is the effect of Acanthopanax senticosus glycoprotein of Example 1 of the present invention on SOD activity in mouse skin tissue;
图2为本发明实施例1的刺五加糖蛋白对小鼠皮肤组织中MDA活力的影响;Fig. 2 is the effect of Acanthopanax senticosus glycoprotein of Example 1 of the present invention on MDA activity in mouse skin tissue;
图3为本发明实施例1的刺五加糖蛋白对小鼠皮肤组织中GSH-Px活力的影响;Fig. 3 is the effect of Acanthopanax senticosus glycoprotein of Example 1 of the present invention on GSH-Px activity in mouse skin tissue;
图4为本发明实施例1的刺五加糖蛋白对小鼠皮肤组织中HYP活力的影响。Fig. 4 is the effect of Acanthopanax senticosus glycoprotein of Example 1 of the present invention on HYP activity in mouse skin tissue.
具体实施方式Detailed ways
为使本发明实施例的目的、技术方案和优点更加清楚,下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purposes, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, but not all of them. Example. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
若未特别指明,本发明实施例中所用的实验试剂和材料等均可市购获得。Unless otherwise specified, the experimental reagents and materials used in the examples of the present invention are all commercially available.
若未具体指明,本发明实施例中所用的技术手段均为本领域技术人员所熟知的常规手段。Unless otherwise specified, the technical means used in the embodiments of the present invention are conventional means well known to those skilled in the art.
其中,纯度的测定如下:Among them, the determination of purity is as follows:
糖蛋白是大分子化合物,其纯度标准不能用通常的小分子化合物纯度标准来衡量,因为即便是糖蛋白纯品,在微观也是不均一的,因此,本发明制备的刺五加糖蛋白纯度表征方式为:刺五加糖蛋白纯度=糖含量+蛋白质含量。Glycoprotein is a macromolecular compound, and its purity standard cannot be measured by the usual purity standard of small molecular compound, because even the pure product of glycoprotein is not uniform at the microscopic level. Therefore, the method for characterizing the purity of the glycoprotein prepared by the present invention is It is: Acanthopanax senticosus glycoprotein purity = sugar content + protein content.
①糖含量测定①Determination of sugar content
测定方法:用苯酚-硫酸法测定不同浓度葡萄糖的吸光度来制定浓度-吸光度标准曲线,再将刺五加糖蛋白样品配成一定浓度的溶液按标准曲线项下操作测其吸光度,代入浓度-吸光度标准曲线方程经计算得到所得糖蛋白中的糖含量。Determination method: use the phenol-sulfuric acid method to measure the absorbance of different concentrations of glucose to formulate a concentration-absorbance standard curve, and then prepare the Acanthopanax senticosus glycoprotein sample into a solution of a certain concentration and measure its absorbance according to the standard curve, and substitute it into the concentration-absorbance standard The curve equation was calculated to obtain the sugar content in the resulting glycoprotein.
标准曲线的制备:精确称取无水葡萄糖标准品2mg,加适量蒸馏水溶解,用50mL容量瓶定容至刻度线,摇匀,配制成40μg/mL的标准溶液。Preparation of standard curve: Accurately weigh 2 mg of anhydrous glucose standard, add appropriate amount of distilled water to dissolve, use a 50 mL volumetric flask to make up to the mark, shake well, and prepare a standard solution of 40 μg/mL.
分别吸取0.1、0.2、0.3、0.4、0.5、0.6、0.7、0.8、0.9及1.0mL葡萄糖标准溶液,各以去离子水补至1.0mL。然后加,入6%的苯酚0.5mL及浓硫酸2.5mL,摇匀,室温放置30min以后于490nm测吸光度,以1.0mL蒸馏水加上0.5mL苯酚和2.5mL浓硫酸为空白,以多糖浓度为横坐标,吸光度为纵坐标绘制标准曲线。由测定结果制作线性回归方程:y=0.0077X+0.223,R2为0.9994,式中y为吸光度值,x为多糖浓度mg/mL。Draw 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 and 1.0 mL of glucose standard solution, respectively, and make up to 1.0 mL with deionized water. Then add, add 0.5 mL of 6% phenol and 2.5 mL of concentrated sulfuric acid, shake well, and place it at room temperature for 30 minutes to measure the absorbance at 490 nm, add 0.5 mL of phenol and 2.5 mL of concentrated sulfuric acid to 1.0 mL of distilled water as a blank, and take the polysaccharide concentration as the horizontal Coordinates, absorbance is the ordinate to draw a standard curve. A linear regression equation was made from the measurement results: y=0.0077X+0.223, R 2 was 0.9994, where y was the absorbance value, and x was the polysaccharide concentration in mg/mL.
精确称取2mg刺五加糖蛋白,加蒸馏水溶解,定容至10mL,样品终浓度为0.2mg/mL;精确吸取各样品溶液1mL,然后按标准曲线制作方法,测定其吸光值。Accurately weigh 2 mg of Acanthopanax senticosus glycoprotein, add distilled water to dissolve, dilute to 10 mL, and the final concentration of the sample is 0.2 mg/mL; accurately draw 1 mL of each sample solution, and then measure its absorbance value according to the standard curve preparation method.
②蛋白质含量测定②Determination of protein content
采用BCA法测定刺五加糖蛋白中的蛋白质含量。将蛋白标准配制液配制成0.5mg/mL的蛋白标准品溶液,各取0、1、2、4、8、12、16、20μL加到96孔板的标准品孔中,加标准品稀释液补足到20μL后,各孔加200μLBCA工作液,37℃放置20-30min,于波长562nm处测定吸光度。以吸光度为纵坐标,蛋白标准溶液浓度为横坐标,绘制标准曲线,拟合回归方程。The protein content of Acanthopanax senticosus glycoprotein was determined by BCA method. The protein standard preparation solution was prepared into 0.5mg/mL protein standard solution, and 0, 1, 2, 4, 8, 12, 16, 20 μL were added to the standard wells of the 96-well plate, and the standard diluent was added. After making up to 20 μL, add 200 μL of BCA working solution to each well, place at 37° C. for 20-30 min, and measure the absorbance at a wavelength of 562 nm. Taking the absorbance as the ordinate and the concentration of the protein standard solution as the abscissa, draw the standard curve and fit the regression equation.
结果显示,蛋白质标准曲线的回归方程为:y=0.8369X+0.1588(r=0.9964),其中x为蛋白质的浓度(单位为mg.mL-1),y为吸光度值。The results showed that the regression equation of the protein standard curve was: y=0.8369X+0.1588 (r=0.9964), where x was the protein concentration (unit: mg.mL -1 ), and y was the absorbance value.
刺五加糖蛋白测定采用BCA试剂盒在酶标仪或紫外-可见分光光度计上进行,均按照试剂盒说明书严格操作。Acanthopanax senticosus glycoproteins were assayed using BCA kits on a microplate reader or UV-Vis spectrophotometer, all of which were strictly operated in accordance with the kit instructions.
综上所述,本发明制备的刺五加糖蛋白纯度=糖含量+蛋白质含量。To sum up, the Acanthopanax senticosus glycoprotein purity prepared by the present invention=sugar content+protein content.
实施例1Example 1
本实施例提供一种刺五加糖蛋白的提取方法,具体步骤如下:The present embodiment provides a method for extracting glycoprotein from Acanthopanax senticosus, and the specific steps are as follows:
(1)预处理:将刺五加药材粉碎成刺五加粗粉;(1) Pre-treatment: pulverize the medicinal materials of Acanthopanax senticosus into coarse powder of Acanthopanax senticosus;
(2)摇床辅助+加热浸提:将步骤(1)得到的刺五加粉末3g与pH=8的PBS缓冲溶液按1:15g/mL的料液比混合均匀,摇床振摇速率为160r/min,30℃下加热浸提12h,提取次数为3次,然后过滤,合并滤液,得到刺五加糖蛋白粗提液;(2) Shaker-assisted + heating extraction: 3 g of Acanthopanax senticosus powder obtained in step (1) and PBS buffer solution with pH=8 were uniformly mixed at a material-to-liquid ratio of 1:15 g/mL, and the shaking rate of the shaking table was 160r/min, heating and leaching at 30°C for 12h, the extraction times were 3 times, then filtered, and the filtrates were combined to obtain the crude extract of Acanthopanax senticosus glycoprotein;
(3)除游离蛋白:将步骤(2)得到的刺五加糖蛋白粗提液采用Sevage法去除游离蛋白,得到刺五加糖蛋白溶液;(3) removal of free protein: the crude extract of Acanthopanax senticosus glycoprotein obtained in step (2) adopts the Sevage method to remove free protein to obtain a solution of Acanthopanax senticosus glycoprotein;
(4)透析冻干:将步骤(3)得到的刺五加糖蛋白溶液装入截留分子量为0.1kDa的透析袋,置于蒸馏水中,透析48h,将透析截留物冷冻干燥,即得刺五加糖蛋白粉末。(4) lyophilization by dialysis: the glycoprotein solution of Acanthopanax senticosus obtained in step (3) was put into a dialysis bag with a molecular weight cut-off of 0.1 kDa, placed in distilled water, dialyzed for 48h, and the dialysis retentate was freeze-dried to obtain Acanthopanax senticosus protein powder.
经检测,本实施例中刺五加糖蛋白得率(得率即指得到的糖蛋白冻干粉的量/3g刺五加粗粉)为8.61%,纯度为73.16%。After testing, in this example, the yield of Acanthopanax senticosus glycoprotein (yield refers to the amount of the obtained glycoprotein freeze-dried powder/3g of Acanthopanax senticosus coarse powder) was 8.61%, and the purity was 73.16%.
实施例2Example 2
本实施例提供一种刺五加糖蛋白的提取方法,具体步骤如下:The present embodiment provides a method for extracting glycoprotein from Acanthopanax senticosus, and the specific steps are as follows:
(1)预处理:将刺五加药材粉碎成刺五加粗粉;(1) Pre-treatment: pulverize the medicinal materials of Acanthopanax senticosus into coarse powder of Acanthopanax senticosus;
(2)摇床辅助+加热浸提:将步骤(1)得到的刺五加粉末3g与pH=8的PBS缓冲溶液按1:15g/mL的料液比混合均匀,摇床振摇速率为160r/min,60℃下加热浸提12h,提取次数为3次,然后过滤,合并滤液,得到刺五加糖蛋白粗提液;(2) Shaker-assisted + heating extraction: 3 g of Acanthopanax senticosus powder obtained in step (1) and PBS buffer solution with pH=8 were uniformly mixed at a material-to-liquid ratio of 1:15 g/mL, and the shaking rate of the shaking table was 160r/min, heating and leaching at 60°C for 12h, the extraction times were 3 times, then filtered, and the filtrates were combined to obtain the crude extract of Acanthopanax senticosus glycoprotein;
(3)除游离蛋白:将步骤(2)得到的刺五加糖蛋白粗提液采用Sevage法去除游离蛋白,得到刺五加糖蛋白溶液;(3) removal of free protein: the crude extract of Acanthopanax senticosus glycoprotein obtained in step (2) adopts the Sevage method to remove free protein to obtain a solution of Acanthopanax senticosus glycoprotein;
(4)透析冻干:将步骤(3)得到的刺五加糖蛋白溶液装入截留分子量为0.1kDa的透析袋,置于蒸馏水中,透析48h,将透析截留物冷冻干燥,即得刺五加糖蛋白粉末。(4) lyophilization by dialysis: the glycoprotein solution of Acanthopanax senticosus obtained in step (3) was put into a dialysis bag with a molecular weight cut-off of 0.1 kDa, placed in distilled water, dialyzed for 48h, and the dialysis retentate was freeze-dried to obtain Acanthopanax senticosus protein powder.
经检测,本实施例中刺五加糖蛋白得率为7.86%,纯度为57.35%。After testing, in this example, the yield of Acanthopanax senticosus glycoprotein was 7.86%, and the purity was 57.35%.
实施例3Example 3
本实施例提供一种刺五加糖蛋白的提取方法,具体步骤如下:The present embodiment provides a method for extracting glycoprotein from Acanthopanax senticosus, and the specific steps are as follows:
(1)预处理:将刺五加药材粉碎成刺五加粗粉;(1) Pre-treatment: pulverize the medicinal materials of Acanthopanax senticosus into coarse powder of Acanthopanax senticosus;
(2)摇床辅助+加热浸提:将步骤(1)得到的刺五加粉末3g与pH=8的PBS缓冲溶液按1:15g/mL的料液比混合均匀,摇床振摇速率为400r/min,30℃下加热浸提12h,提取次数为3次,然后过滤,合并滤液,得到刺五加糖蛋白粗提液;(2) Shaker-assisted + heating extraction: 3 g of Acanthopanax senticosus powder obtained in step (1) and PBS buffer solution with pH=8 were uniformly mixed at a material-to-liquid ratio of 1:15 g/mL, and the shaking rate of the shaking table was 400r/min, heating and leaching at 30°C for 12h, the extraction times were 3 times, then filtered, and the filtrates were combined to obtain the crude extract of Acanthopanax senticosus glycoprotein;
(3)除游离蛋白:将步骤(2)得到的刺五加糖蛋白粗提液采用Sevage法去除游离蛋白,得到刺五加糖蛋白溶液;(3) removal of free protein: the crude extract of Acanthopanax senticosus glycoprotein obtained in step (2) adopts the Sevage method to remove free protein to obtain a solution of Acanthopanax senticosus glycoprotein;
(4)透析冻干:将步骤(3)得到的刺五加糖蛋白溶液装入截留分子量为0.1kDa的透析袋,置于蒸馏水中,透析48h,将透析截留物冷冻干燥,即得刺五加糖蛋白粉末。(4) lyophilization by dialysis: the glycoprotein solution of Acanthopanax senticosus obtained in step (3) was put into a dialysis bag with a molecular weight cut-off of 0.1 kDa, placed in distilled water, dialyzed for 48h, and the dialysis retentate was freeze-dried to obtain Acanthopanax senticosus protein powder.
经检测,本实施例中刺五加糖蛋白得率为9.12%,纯度为68.56%。After testing, in this example, the yield of Acanthopanax senticosus glycoprotein was 9.12%, and the purity was 68.56%.
实施例4Example 4
本实施例提供一种刺五加糖蛋白的提取方法,具体步骤如下:The present embodiment provides a method for extracting glycoprotein from Acanthopanax senticosus, and the specific steps are as follows:
(1)预处理:将刺五加药材粉碎成刺五加粗粉;(1) Pre-treatment: pulverize the medicinal materials of Acanthopanax senticosus into coarse powder of Acanthopanax senticosus;
(2)摇床辅助+加热浸提:将步骤(1)得到的刺五加粉末3g与pH=7的PBS缓冲溶液按1:20g/mL的料液比混合均匀,摇床振摇速率为200r/min,40℃下加热浸提24h,提取次数为4次,然后过滤,合并滤液,得到刺五加糖蛋白粗提液;(2) Shaker-assisted + heating extraction: 3 g of Acanthopanax senticosus powder obtained in step (1) and PBS buffer solution with pH=7 were uniformly mixed at a material-to-liquid ratio of 1:20 g/mL, and the shaking rate of the shaking table was 200r/min, heating and leaching at 40°C for 24h, the extraction times were 4 times, then filtered, and the filtrates were combined to obtain the crude extract of Acanthopanax senticosus glycoprotein;
(3)除游离蛋白:将步骤(2)得到的刺五加糖蛋白粗提液采用Sevage法去除游离蛋白,得到刺五加糖蛋白溶液;(3) removal of free protein: the crude extract of Acanthopanax senticosus glycoprotein obtained in step (2) adopts the Sevage method to remove free protein to obtain a solution of Acanthopanax senticosus glycoprotein;
(4)透析冻干:将步骤(3)得到的刺五加糖蛋白溶液装入截留分子量为0.1kDa的透析袋,置于蒸馏水中,透析48h,将透析截留物冷冻干燥,即得刺五加糖蛋白粉末。(4) lyophilization by dialysis: the glycoprotein solution of Acanthopanax senticosus obtained in step (3) was put into a dialysis bag with a molecular weight cut-off of 0.1 kDa, placed in distilled water, dialyzed for 48h, and the dialysis retentate was freeze-dried to obtain Acanthopanax senticosus protein powder.
经检测,本实施例中刺五加糖蛋白得率为8.21%,纯度为62.36%。After testing, in this example, the yield of Acanthopanax senticosus glycoprotein was 8.21%, and the purity was 62.36%.
应用例刺五加糖蛋白的皮肤抗氧化实验Application Example Skin Antioxidant Experiment of Acanthopanax senticosus glycoprotein
通过实验验证本发明实施例1制得的刺五加糖蛋白的抗氧化作用,实验方法及结果如下:The antioxidant effect of the Acanthopanax senticosus glycoprotein prepared in Example 1 of the present invention was verified by experiments, and the experimental methods and results were as follows:
1.实验对象:SD大鼠。1. Subject: SD rats.
2.指标测定及分析方法2. Indicator measurement and analysis methods
皮肤组织中SOD、MDA、GSH-Px、HYP的测定,在酶标仪或紫外-可见分光光度计上进行,均按照试剂盒说明书严格操作。The determination of SOD, MDA, GSH-Px, and HYP in skin tissue was carried out on a microplate reader or a UV-Vis spectrophotometer, which was strictly operated in accordance with the kit instructions.
超氧化物歧化酶(SOD)试剂盒(货号:A001-1,生产批号:20210423)、丙二醛(MDA)测定盒(货号:A003-1-2,生产批号:20201203)、谷胱甘肽过氧化物酶(GSH-Px)测试盒(货号:A005-1-1,生产批号:20201222)、羟脯氨酸(碱水解法)试剂盒(货号:A030-2-1,生产批号:20201223)均由南京建成生物工程研究所提供。Superoxide Dismutase (SOD) Kit (Item No. A001-1, Production Lot: 20210423), Malondialdehyde (MDA) Assay Kit (Item No. A003-1-2, Production Lot: 20201203), Glutathione Peroxidase (GSH-Px) Test Kit (Item No.: A005-1-1, Production Lot: 20201222), Hydroxyproline (Alkaline Hydrolysis) Kit (Item No. A030-2-1, Production Lot: 20201223) ) were provided by Nanjing Jiancheng Bioengineering Institute.
3.动物分组、造模、给药3. Animal grouping, modeling, administration
选取SD级雌性大鼠30只,随机分为空白组、模型组、阳性对照组、刺五加糖蛋白高、中、低剂量组,每组5只。使用电推剔除所有组别小鼠背部约3cm×4cm区域的背毛,除毛当天不宜给予紫外照射,实验开始后,每隔3天用同样的方法对所有组别小鼠进行一次除毛。接下来进行紫外照射,照射前对UVA及UVB灯管辐射强度进行测量,利用紫外辐照测定仪测定最小红斑量(minimum erythema quantity)为37.34J/cm2。根据最小红斑量,设定照射时间。将剃毛后的大鼠放入自制的紫外灯箱中,固定照射距离为10cm,进行紫外(UVA+UVB)照射。第一周0.5h/每天,第二周1h/每天,第三周2h/每天,此后维持2h/每天直至大鼠背部皮肤出现干燥,起皮,甚至局部有溃烂现象即为造模结束。采用造模后给药的方法,除空白组外,阳性对照组背部涂抹维生素E溶液10mg/mL 0.5mL,刺五加糖蛋白高、中、低剂量组背部涂抹刺五加总糖蛋白25mg/mL、10mg/mL、1mg/mL 0.5mL,各组自由摄食饮水,连续4周。Thirty SD female rats were selected and randomly divided into blank group, model group, positive control group, and Acanthopanax senticosus glycoprotein high, medium and low dose groups, with 5 rats in each group. The dorsal hair in the area of about 3cm × 4cm on the back of the mice in all groups was removed by electric shaving. It is not suitable to give ultraviolet irradiation on the day of hair removal. After the start of the experiment, the same method was used to remove the hair of all groups of mice every 3 days. Next, ultraviolet irradiation was performed, and the radiation intensity of UVA and UVB lamps was measured before irradiation, and the minimum erythema quantity was determined to be 37.34 J/cm 2 by an ultraviolet radiation meter. The irradiation time was set according to the minimum amount of erythema. The shaved rats were placed in a self-made ultraviolet light box, and the irradiation distance was fixed at 10 cm, and ultraviolet (UVA+UVB) irradiation was performed. 0.5h/day in the first week, 1h/day in the second week, 2h/day in the third week, and then maintained for 2h/day until the skin on the back of the rat was dry, peeled, or even partially ulcerated. The method of administration after modeling was adopted. Except for the blank group, the positive control group was smeared with vitamin E solution 10mg/mL 0.5mL on the back, and the high, medium and low dose groups of Acanthopanax senticosus were smeared with the total glycoprotein of Acanthopanax senticosus 25mg/mL. , 10mg/mL, 1mg/mL 0.5mL, each group had free access to food and water for 4 consecutive weeks.
4.皮肤处理4. Skin Treatment
末次给药后,颈椎脱臼处死,剪下皮肤组织,剥除周围结缔组织,新鲜称重,记录数据。After the last administration, the patients were sacrificed by cervical dislocation, the skin tissue was cut, the surrounding connective tissue was stripped, freshly weighed, and the data were recorded.
5.组织匀浆的制备5. Preparation of Tissue Homogenates
将准确称重后的皮肤组织加入9倍体积的生理盐水,于匀浆机处理制备匀浆,再将匀浆液4000r/min离心20min,取上清液得10%皮肤组织匀浆,冷冻备用。The accurately weighed skin tissue was added to 9 times the volume of normal saline, processed in a homogenizer to prepare a homogenate, and then the homogenate was centrifuged at 4000 r/min for 20 min, and the supernatant was taken to obtain a 10% skin tissue homogenate, which was frozen for later use.
6.数据处理6. Data processing
实验数据采用SPSS16.0软件进行统计分析,以平均值和标准差(x士S)表示,用t检验法进行组间比较,以P<0.05或P<0.01为差异,说明组间差别有统计学意义。SPSS16.0 software was used for statistical analysis of experimental data, expressed as mean and standard deviation (x±S), and t-test was used for comparison between groups, with P<0.05 or P<0.01 as the difference, indicating that the difference between groups was statistically significant study meaning.
7.实验结果7. Experimental results
7.1刺五加糖蛋白对小鼠皮肤组织中SOD活力的影响7.1 Effects of Acanthopanax senticosus glycoprotein on SOD activity in mouse skin tissue
结果如图1所示,由图可知,与空白组相比,模型组大鼠皮肤中的SOD活力明显下降。与模型组相比,刺五加糖蛋白给药组的SOD活力明显增加,且随剂量呈正相关。刺五加糖蛋白组的SOD活力高于阳性组,说明刺五加糖蛋白与维生素E有类似的抗氧化功效,其作用可能优于维生素E。The results are shown in Figure 1. It can be seen from the figure that compared with the blank group, the SOD activity in the skin of the rats in the model group was significantly decreased. Compared with the model group, the SOD activity of the Acanthopanax senticosus glycoprotein administration group was significantly increased, and it was positively correlated with the dose. The SOD activity of Acanthopanax senticosus glycoprotein group was higher than that of the positive group, indicating that Acanthopanax senticosus glycoprotein and vitamin E have similar antioxidant effects, and its effect may be better than that of vitamin E.
7.2刺五加糖蛋白对小鼠皮肤组织中MDA活力的影响7.2 Effect of Acanthopanax senticosus glycoprotein on MDA activity in mouse skin tissue
结果如图2所示,由图可知,与空白组相比,模型组大鼠皮肤中的MDA含量明显上升。与模型组相比,刺五加糖蛋白给药组的MDA含量明显降低,随着刺五加糖蛋白剂量增加,MDA含量逐渐减少。刺五加糖蛋白组的MDA含量低于阳性组,说明刺五加糖蛋白的抑制氧化应激生成丙二醛的效果较VE好。The results are shown in Figure 2. It can be seen from the figure that compared with the blank group, the MDA content in the skin of the rats in the model group was significantly increased. Compared with the model group, the MDA content in the Acanthopanax senticosus glycoprotein administration group was significantly decreased, and the MDA content gradually decreased with the increase of the Acanthopanax senticosus glycoprotein dose. The content of MDA in the Acanthopanax senticosus glycoprotein group was lower than that in the positive group, indicating that the effect of Acanthopanax senticosus glycoprotein in inhibiting oxidative stress and MDA production was better than that of VE.
7.3刺五加糖蛋白对小鼠皮肤组织中GSH-Px活力的影响7.3 Effects of Acanthopanax senticosus glycoprotein on GSH-Px activity in mouse skin tissue
结果如图3所示,由图可知,与空白组相比,模型组大鼠皮肤中的GSH-Px活力明显下降。与模型组相比,刺五加糖蛋白给药组的GSH-Px活力明显增加,且随剂量呈正相关。刺五加糖蛋白组的GSH-Px活力高于阳性组,说明刺五加糖蛋白能促进体内产生谷胱甘肽过氧化物酶,其具有清除自由基和衍生物的作用,还减少脂质过氧化物的形成,增强机体抗氧化损伤的能力。The results are shown in Figure 3. It can be seen from the figure that compared with the blank group, the GSH-Px activity in the skin of the rats in the model group was significantly decreased. Compared with the model group, the GSH-Px activity of the Acanthopanax senticosus glycoprotein administration group was significantly increased, and it was positively correlated with the dose. The GSH-Px activity of the Acanthopanax senticosus glycoprotein group was higher than that of the positive group, indicating that the Acanthopanax senticosus glycoprotein can promote the production of glutathione peroxidase in the body, which has the effect of scavenging free radicals and derivatives, and also reduces lipid peroxidation It enhances the body's ability to resist oxidative damage.
7.4刺五加糖蛋白对小鼠皮肤组织中HYP活力的影响7.4 Effects of Acanthopanax senticosus glycoprotein on HYP activity in mouse skin tissue
结果如图4所示,由图可知,与空白组相比,模型组大鼠皮肤中的HYP含量明显下降。与模型组相比,刺五加糖蛋白给药组的HYP含量明显增加,且随剂量呈正相关。羟脯氨酸是胶原蛋白含有的一种主要氨基酸,胶原蛋白是构成皮肤结缔组织细胞间质胶原纤维的主要成分,说明刺五加糖蛋白能够促进受损肌肤生成胶原蛋白,修复损伤。The results are shown in Figure 4. It can be seen from the figure that compared with the blank group, the HYP content in the skin of the rats in the model group was significantly decreased. Compared with the model group, the content of HYP in the Acanthopanax senticosus glycoprotein administration group was significantly increased, and it was positively correlated with the dose. Hydroxyproline is a major amino acid contained in collagen. Collagen is the main component of collagen fibers in the interstitial cells of skin connective tissue, indicating that Acanthopanax senticosus can promote damaged skin to generate collagen and repair damage.
综上所述,刺五加糖蛋白具有显著的抗氧化及对皮肤光老化具有较好的修复作用,对刺五加应用于抗氧化药品、保健食品以及刺五加护肤品的研发最大化开发利用提供了参考依据。To sum up, the glycoprotein of Acanthopanax senticosus has significant anti-oxidation and has a good repairing effect on skin photoaging, which maximizes the development and utilization of Acanthopanax senticosus in the research and development of antioxidant drugs, health food and skin care products of Acanthopanax senticosus References are provided.
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, but not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that it can still be Modifications are made to the technical solutions described in the foregoing embodiments, or some technical features thereof are equivalently replaced; and these modifications or replacements do not make the essence of the corresponding technical solutions depart from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210056639.6A CN114276408A (en) | 2022-01-18 | 2022-01-18 | Extraction method and application of acanthopanax senticosus glycoprotein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210056639.6A CN114276408A (en) | 2022-01-18 | 2022-01-18 | Extraction method and application of acanthopanax senticosus glycoprotein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114276408A true CN114276408A (en) | 2022-04-05 |
Family
ID=80881180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210056639.6A Pending CN114276408A (en) | 2022-01-18 | 2022-01-18 | Extraction method and application of acanthopanax senticosus glycoprotein |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114276408A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030043191A (en) * | 2001-11-27 | 2003-06-02 | 주식회사 코오롱 | Increasing immune composition contained korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide extract which were extracted korean acanthopanax senticosus, and food or food additives and medicine containing above increasing immune composition |
| KR20040060913A (en) * | 2004-06-25 | 2004-07-06 | 주식회사 코오롱 | Pharmaceitical composition containing composition for immune contained korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide extract which were extracted korean acanthopanax senticosus |
| US20040142047A1 (en) * | 2001-06-02 | 2004-07-22 | Taek-Joon Yoon | Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| CN103610730A (en) * | 2013-11-20 | 2014-03-05 | 江苏众红生物工程创药研究院有限公司 | Hypoglycemic luffa seed extract as well as preparation method and application thereof |
| CN106188258A (en) * | 2016-08-08 | 2016-12-07 | 山西中医学院 | A kind of method extracting Radix Polygalae glycoprotein |
| CN107383230A (en) * | 2017-08-22 | 2017-11-24 | 广州聚注通用技术研究院有限公司 | The extracting method of Radix Et Caulis Acanthopanacis Senticosi polysaccharide with radioresistance activity of fighting against senium and application |
| CN108191952A (en) * | 2018-03-22 | 2018-06-22 | 吉林大学 | A kind of extraction separation method of gen-seng haulms albumen |
| CN110283242A (en) * | 2019-07-30 | 2019-09-27 | 河南赛诺特生物技术有限公司 | A method of extracting phytolectin |
| CN110407948A (en) * | 2018-04-26 | 2019-11-05 | 青岛农业大学 | A kind of extraction process of Acanthopanax senticosus polysaccharide |
| CN111961141A (en) * | 2020-07-20 | 2020-11-20 | 广州青岚生物科技有限公司 | Acanthopanax senticosus homogeneous polysaccharide and preparation method and application thereof |
-
2022
- 2022-01-18 CN CN202210056639.6A patent/CN114276408A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040142047A1 (en) * | 2001-06-02 | 2004-07-22 | Taek-Joon Yoon | Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| KR20030043191A (en) * | 2001-11-27 | 2003-06-02 | 주식회사 코오롱 | Increasing immune composition contained korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide extract which were extracted korean acanthopanax senticosus, and food or food additives and medicine containing above increasing immune composition |
| KR20040060913A (en) * | 2004-06-25 | 2004-07-06 | 주식회사 코오롱 | Pharmaceitical composition containing composition for immune contained korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide extract which were extracted korean acanthopanax senticosus |
| CN103610730A (en) * | 2013-11-20 | 2014-03-05 | 江苏众红生物工程创药研究院有限公司 | Hypoglycemic luffa seed extract as well as preparation method and application thereof |
| CN106188258A (en) * | 2016-08-08 | 2016-12-07 | 山西中医学院 | A kind of method extracting Radix Polygalae glycoprotein |
| CN107383230A (en) * | 2017-08-22 | 2017-11-24 | 广州聚注通用技术研究院有限公司 | The extracting method of Radix Et Caulis Acanthopanacis Senticosi polysaccharide with radioresistance activity of fighting against senium and application |
| CN108191952A (en) * | 2018-03-22 | 2018-06-22 | 吉林大学 | A kind of extraction separation method of gen-seng haulms albumen |
| CN110407948A (en) * | 2018-04-26 | 2019-11-05 | 青岛农业大学 | A kind of extraction process of Acanthopanax senticosus polysaccharide |
| CN110283242A (en) * | 2019-07-30 | 2019-09-27 | 河南赛诺特生物技术有限公司 | A method of extracting phytolectin |
| CN111961141A (en) * | 2020-07-20 | 2020-11-20 | 广州青岚生物科技有限公司 | Acanthopanax senticosus homogeneous polysaccharide and preparation method and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| 孟庆繁 等: ""刺五加多糖的提取及其抗氧化性"", 《吉林大学学报(理学版)》 * |
| 李天金;翟树平;李洁;王立安;: "刺五加多糖提取纯化工艺的优化", 安徽农业科学, no. 17 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10918659B2 (en) | Compositions and methods of aloe polysaccharides | |
| CN104922171A (en) | Use of red quinoa extract for preparing compositions for promoting collagen production and anti-aging skin | |
| CN103845272A (en) | Earthworm extract having skin aging resisting effect and preparation method and application thereof | |
| CN115490780A (en) | Extraction method and application of crude extract of Sargassum fucoidan | |
| CN104522664B (en) | Health food with capability of improving immunity and preparation method of health food | |
| CN106397629A (en) | Method for extracting chondroitin sulfate from sturgeon bones, chondroitin sulfate extracted through method, and application of chondroitin sulfate | |
| CN118406167A (en) | Atractylodes macrocephala polysaccharide, gel and application thereof | |
| CN109833266A (en) | Cosmetic composition | |
| CN108402472A (en) | A kind of lady's silkworm chrysalis extraction bioprotein | |
| CN114276408A (en) | Extraction method and application of acanthopanax senticosus glycoprotein | |
| CN101167755B (en) | Preparation method and application of centipede polysaccharide protein complex with anti-tumor activity | |
| CN116694721B (en) | Ganoderma glycopeptides and their preparation methods and applications as well as Ganoderma glycopeptide microemulsions and creams | |
| CN119423311A (en) | A kind of jujube seed peptide zinc chelate and its preparation method and application | |
| CN118580310A (en) | A polypeptide for resisting skin photoaging and its application | |
| KR20170068882A (en) | Osmotic enzyme fermentation natural liposome containing mushroom, process for the preparation thereof, and cosmetic, food or pharmaceutical composition comprising the same | |
| CN102274241B (en) | Method for extracting sheep embryo extract and medicinal composition comprising same | |
| CN115836702A (en) | Composite plant peptide tablet candy with immunity improving function and preparation method thereof | |
| TWI726184B (en) | Polysaccharides of brown algae, method of producing the same and application thereof | |
| CN1160095C (en) | Antisanility health-care cream and its preparing process | |
| CN116687959B (en) | Chondroitin sulfate biopolyamine complex, preparation method and use thereof | |
| CN114350735B (en) | Method for extracting small molecular polypeptides from chick embryo | |
| RU2839436C1 (en) | Method of producing tobacco exosomes | |
| CN117487376B (en) | Method for extracting melanin from inonotus obliquus by deep eutectic solution | |
| CN118141871B (en) | Fresh gastrodia elata corn starch curing liquid capable of resisting UVB damage as well as preparation method and application thereof | |
| CN110106221A (en) | Sea cucumber oligopeptides and the preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220405 |